Rchr
J-GLOBAL ID:200901018094479244
Update date: Jan. 17, 2008
Naito Akihiro
ナイトウ アキヒロ | Naito Akihiro
Affiliation and department:
Former Institution /Organization Experimental Pathology & Chemotherapy Division
About Former Institution /Organization Experimental Pathology & Chemotherapy Division
Search "Former Institution /Organization Experimental Pathology & Chemotherapy Division"
Job title:
Researcher
Research keywords (4):
Cancer
, Exparimental Pathology
, 癌
, 実験病理学
Research theme for competitive and other funds (2):
実験病理学
Experimental Pathology
MISC (9):
実験医学別冊バイオサイエンス用語ライブラリー、斉藤+竹森利忠編. 羊土社(1995), p.58-59
The gene responsible for LEC hepatitis, located on rat chromosome 16, is the homologue to the human Wilson disense gene. Biochem. Biophys. Res. Commun. (1994), 202, 512-518
Stability of C3 convertase in the rat classical pathway. Microbiol. Immunol. (1997), 41, 621-624
Role of conserved amino acid residues in the complementary determining regions of Hapten-Antibody Interaction of Anti NP antibodys. Mol.Immunol. (1995), 32, 983-990
Regulation of promoter & intron enhancer activity in immunoglobulin heavy chain gene through late stage of B cell development. Microbiol. Immual. (1998), 42, 399-405
more...
Education (4):
Nagoya City University Medicin Medicin
Nagoya City University Graduate School of Pharmaceutical Sciences
Nagoya City University, Faculty of Pharmacy
Nagoya City University, Graduate School of Pharmacy
Professional career (1):
Doctor of Pharmacy
Work history (7):
1999 - 国立がんセンター研究所研究員
1999 - National Cancer Center Research Inst. researcher
1998 - 国立がんセンター研究所リサーチレジデント
1998 - National Cancer Center Research Inst.
1997 - 東亜合成株式会社つくば研究所研究員
1997 - Toagosei Co. Ltd., Tsukuba Research. Lab., researcher
research residence
Show all
Association Membership(s) (6):
日本病理学会
, 日本癌学会
, 疾患モデル学会
, Japanese Society of animal models for human diserse
, Japanese Society of Pathology
, Japanese Cancer Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM